In recent years the stem cell science has increasingly focused on mitigating the loss of vision through Ophthalmology. Cell based therapies are showing tremendous promise in mitigating many acquired and hereditary vision problems. Age Related Macular Degeneration in particular is under scrutiny as a condition that is likely to respond to adult mesenchymal cell therapy.
Ophthalmology and Cell Surgical Network
At Cell Surgical Network, we have been studying the effects of SVF (rich in mesenchymal stem cells and growth factors) on various ophthalmologic conditions including Macular degeneration, retinitis pigmentosa, diabetic retinopathy, retinal detachments, Leber’s optic neuropathy and optic neuritis. In collaboration with our ophthalmology consultants we have designed protocols for visual loss conditions that emphasize safety and efficacy. The deployment protocol performed under local anesthesia is all done as an outpatient at the time of SVF harvesting and procurement. The entire cellular surgical procedure takes approximately 3 hours.